Literature DB >> 7500770

NSAIDs, Cox-2 inhibitors, and the gut.

J Hayllar, I Bjarnason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7500770     DOI： 10.1016/s0140-6736(95)91962-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management.

Authors:  Usha K Coblijn; Sjoerd M Lagarde; Steve M M de Castro; Sjoerd D Kuiken; Bart A van Wagensveld
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

Review 2.  Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review.

Authors:  Usha K Coblijn; Amin B Goucham; Sjoerd M Lagarde; Sjoerd D Kuiken; Bart A van Wagensveld
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 3.  Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.

Authors:  P A Scott; G H Kingsley; C M Smith; E H Choy; D L Scott
Journal:  Ann Rheum Dis       Date:  2007-03-07       Impact factor: 19.103

Review 4.  Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.

Authors:  Elham Rahme; Alan N Barkun; Viviane Adam; Marc Bardou
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.